Reglan

The prescription drug Reglan and its generic counterpart metoclopramide is a medication approved for the short-term treatment of gastrointestinal problems such as gastroesophageal reflux disease (GERD), gastroesophageal reflux (GER), and diabetic gastroparesis in adults and children. However, since its introduction to the U.S. market, there have been numerous reports of adverse health affects associated with Reglan use.

Dangerous Side Effects Associated with Reglan Use

The Food and Drug Administration's Adverse Event Reporting System has indentified several cases of muscle disorders among patients who were taking Reglan; the majority of those affected were children taking Reglan, as well as patients using Reglan as a long-term treatment. Some of the muscle disorders linked to Reglan use include:

  • Tardive dyskinesia
  • Neuroleptic malignant syndrome (NMS)
  • Dystonia

All of these conditions are neurological disorders characterized by abnormal muscle movement or rigidity of the body. In response to the potential risks associated with Reglan use, the FDA required the manufacturer of Reglan to take action.

FDA Warnings

Baxter Healthcare manufactures Reglan and its generic counterpart. In February of 2009, the FDA required Baxter to update the safety labels on both medications, warning patients about the potential link between Reglan use and the development of muscle disorders such as tardive dyskinesia.

Legal Information

Find more information about Reglan litigation:

Consult a Reglan Attorney

If you or a loved one has suffered serious health affects after Reglan use, it is important to speak to a lawyer as soon as possible. You may be eligible for compensation for your injuries. A qualified Reglan attorney can review your claim and determine if you have a viable lawsuit.

Keyword Tags: pharmaceutical litigation, defective drugs

Still Have a Question? Ask a Lawyer in Your Area